Recent Posts
- AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF EPRONTIA™ (topiramate) oral solution
- Azurity Pharmaceuticals Completes Acquisition of Arbor Pharmaceuticals
- Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of One Lot of Firvanq® (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Due to a Mix-Up of the Diluent Included in the Kit
- Azurity Pharmaceuticals to Acquire and Merge with Arbor Pharmaceuticals
- Azurity Pharmaceuticals Announces Three New Neurology Products
Recent Comments